Emergency Pharmaceutical Care in Ed and Cardiac ICU: Toxicology, Infectious Disease, Pharmacoeconomy as Synergic Knowledge Instrument to Reduce Mortality Rate and Healthcare Cost 2019

Mauro Luisetto*

Received: January 18, 2019;   Published: January 25, 2019

DOI: 10.32474/ACR.2018.01.000122

Full Text PDF

To view the Full Article   Peer-reviewed Article PDF

Abstract

In this work we discuss about healthcare advantages related clinical pharmacist to take part in stabile way in medical team to improve clinical-economical outcomes (and the role played by clinical pharmacist with medicine laboratory and imaging tools to monitoring therapy). The role played by hospital clinical pharmacist in emergency department or in ICU or in other relevant wards like infectious disease and other is a real fact with reduction in mortality rate and right cost containment as reported in biomedical literature. The high pharmacist specialization in field like toxicology, antidothes, antimicrobial agents, nuclear medicine, imaging and laboratory medicine contribute in every medical team to better Obtain efficacy clinical outcomes.

Abstract| Introduction| Material and Methods| Methods| A Practical Experience: Results| Results| Discussion| Conclusion| References|